PP405 is a new hairgrowthstimulant different from Minoxidil, currently in phase 2 trials. Users discuss its potential, safety concerns, and the long wait before it might be available.
The conversation discusses various hairgrowth treatments, including topical and oral minoxidil, microneedling, LLLT, PRP, exosomes, latanoprost, copper peptides, and upcoming treatments like PP405 and Vdphl01. It also covers managing side effects of minoxidil, such as dry scalp, and mentions the use of dutasteride and finasteride for hair loss.
Hair loss discussion mentions using estrogen mixed with growthstimulants like oral minoxidil for scalp hairgrowth. Idea proposed for an artificial SARM-estrogen that only affects hair without body side effects.
Glycosaminoglycans are important for hairgrowth, and combining minoxidil with tretinoin and Biopeptide-CL may enhance hairgrowth by boosting glycosaminoglycan levels and improving the hair follicle environment. Users discussed the potential effectiveness and future of these treatments.
The conversation discusses alternative hairgrowth treatments to minoxidil, including Stemoxydine, Tretinoin, adenosine, Baicalin, castor oil, Latanoprost/bimatoprost, and Redensyl. Users share their experiences and opinions on the efficacy of these treatments.